Participate in the CREDENCE study on type 2 diabetes and kidney health (Melbourne) 10 December 2014 Do you have type 2 diabetes? Do you have problems with your kidneys? If the answer to both questions is Yes, you may be able to take part in a clinical research study. The CREDENCEtm Study is looking at an investigational (study) medication (taken as a daily capsule) that may help protect the kidneys in people with type 2 diabetes. They are looking for people who: Are 30 years of age or older Have a diagnosis of type 2 diabetes Have kidney problems related to their diabetes Are currently taking medicines to control their kidney problems? If you choose to take part in the CREDENCEtm Study, you will be looked after by an experienced study team who will carefully monitor your health and support your diabetes management. You will continue to take your current diabetes medications. For more information please contact: Nicky Robinson on 9496 2645 or Clinical [email protected] This study has been approved by the Austin Health Human Research Ethics Committee. HREC: 28431754DNE3001
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading